Artelo Biosciences, Inc (ARTL)

Etorro trading 970x250
Artelo Biosciences, Inc (ARTL) Logo

About Artelo Biosciences, Inc

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1 clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences has research collaboration with Trinity College Dublin to Investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was founded in 2011 and is headquartered in La Jolla, California. Address: 888 Prospect Street, La Jolla, CA, United States, 92037

Artelo Biosciences, Inc News and around…

Latest news about Artelo Biosciences, Inc (ARTL) common stock and company :

New Study Comparing Plant-Derived and Synthetic CBD Efficacy Opens Door to Exciting Medical Uses of Cannabidiol
23 Sep, 2021 FinancialContent

Image Provided by Bill Oxford on Unsplash The following article is sponsored by the clinical communications unit of Redington, Inc. ...

Artelo Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
08 Sep, 2021 FinancialContent
12 Health Care Stocks Moving In Tuesday's After-Market Session
24 Aug, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 51.24% to $23.14 during Tuesday's after-market session. Regencell Bioscience's ...

Artelo Biosciences to Present at the Q3 Virtual Investor Summit on August 18th
11 Aug, 2021 Yahoo! Finance

Solana Beach, California--(Newsfile Corp. - August 11, 2021) - Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, today announced that management will present at the Q3 Virtual Investor Summit, hosted by the Investor Summit Group, being held virtually on August 17-18, 2021.Andrew Yates, PhD, Senior Vice President and Chief Scientific Officer is s

Artelo Biosciences Announces Publication of Study Results Comparing the Pharmacological Effects of Plant-Derived Versus Synthetic Cannabidiol in Human Cell Lines
04 Aug, 2021 FinancialContent
Ladenburg Thalmann to Host R&D Showcase Featuring Artelo Biosciences’ CAReS Study on July 28, 2021
21 Jul, 2021 FinancialContent
Artelo Biosciences Reports Third Quarter Fiscal 2021 Financial Results and Provides Business Update
12 Jul, 2021 FinancialContent
Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th
07 Jul, 2021 FinancialContent
Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th
07 Jul, 2021 Yahoo! Finance

LA JOLLA, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, today announced that management will be presenting and hosting 1x1 meetings during the Ladenburg Thalmann Healthcare Conference taking place virtually July 13-14, 2021. Gregory D. Gorgas, Artelo’s President and Chief Executive Officer, is schedu

12 Health Care Stocks Moving In Friday's After-Market Session
02 Jul, 2021 FinancialContent

Gainers Odonate Therapeutics (NASDAQ:ODT) shares increased by 20.46% to $4.18 during Friday's after-market session. Today's trading ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
25 Jun, 2021 FinancialContent

Gainers Osmotica Pharmaceuticals (NASDAQ:OSMT) shares increased by 39.08% to $3.95 during Friday's pre-market ...

New Cannabinoid-Based Drug Candidates from Artelo Biosciences Show Promise as Cancer and Mental Health Treatments; Key Data Due Before Year End
24 Jun, 2021 FinancialContent

The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in ...

Artelo Biosciences Announces Two Poster Presentations Featured at the 31st Annual ICRS Symposium
22 Jun, 2021 FinancialContent
Artelo Biosciences to Present at the LD Micro Virtual Invitational XI on June 9th
02 Jun, 2021 FinancialContent
Artelo Biosciences to Participate at the Benzinga Global Small Cap Conference on May 13, 2021
06 May, 2021 Yahoo! Finance

La Jolla, California--(Newsfile Corp. - May 6, 2021) - Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system, today announced that Gregory D. Gorgas, President and Chief Executive Officer of Artelo Biosciences, is scheduled to present at the Benzinga Global Small Cap Conference at 4:10 PM EST / 1:10 PM PST, on Thursday, May 13, 2021. The Benzinga ...

Kintara Therapeutics Appoints Tamara A. Seymour to Board of Directors
04 May, 2021 Yahoo! Finance

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced the appointment of Tamara A. Seymour to the Company's Board of Directors replacing John Liatos, who will continue in his role as Kintara's Senior Vice President of Business Development.

12 Health Care Stocks Moving In Monday's Pre-Market Session
26 Apr, 2021 FinancialContent

Gainers Ocugen (NASDAQ:OCGN) shares rose 13.81% to $10.96 during Monday's pre-market session. The market value of ...

Cannabis-Centric Bio-Pharma Stocks Category Declined Almost 3% This Past Week
25 Apr, 2021 FinancialContent

Introducing our new Cannabis-Centric Bio-Pharma Stocks Index of the 13 clinical-stage biopharmaceutical companies involved exclusively in the development of drugs using CBD and THC.

We're Hopeful That Artelo Biosciences (NASDAQ:ARTL) Will Use Its Cash Wisely
20 Apr, 2021 Yahoo! Finance

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

12 Health Care Stocks Moving In Monday's After-Market Session
19 Apr, 2021 FinancialContent

Gainers Obalon Therapeutics (NASDAQ:OBLN) shares moved upwards by 6.04% to $2.63 during Monday's after-market session. At the ...

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Monday Morning
19 Apr, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's the start of a new week and InvestorPlace is kicking it off with a look at the biggest pre-market movers for Monday morning. The post Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Monday Morning appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner Stock Prodigy Who Found NIO at $2… Says Buy THIS Now

24 Stocks Moving in Monday's Pre-Market Session
19 Apr, 2021 FinancialContent

Gainers InspireMD, Inc. (NYSE: NSPR) rose 29.3% to $0.53 in pre-market trading. InspireMD, last week, announced a 1-for-15 reverse ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
14 Apr, 2021 FinancialContent

Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 18.37% to $31.44 during Wednesday's regular session. ...

Artelo Biosciences Reports Second Quarter Fiscal 2021 Financial Results and Provides Business Update
13 Apr, 2021 FinancialContent
Artelo Biosciences Doses First Patient in CAReS Study with ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
12 Apr, 2021 FinancialContent
33 Stocks Moving in Tuesday's Pre-Market Session
30 Mar, 2021 FinancialContent

Gainers VirTra, Inc. (NASDAQ: VTSI) rose 125.5% to $10.78 in pre-market trading after the company reported better-than-expected Q4 ...

4 Penny Stocks On Robinhood You Might’ve Missed This Week
19 Mar, 2021 FinancialContent
Artelo Biosciences Accepted into the Alderley Park Oncology Development Program for FABP5 Inhibitor Biomarker Development
19 Mar, 2021 FinancialContent
Artelo Biosciences, Inc. to Present at the Q1 Virtual Investor Summit on March 23rd
11 Mar, 2021 FinancialContent
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
10 Mar, 2021 FinancialContent

Gainers MediciNova (NASDAQ:MNOV) stock rose 88.38% to $10.7 during Wednesday's pre-market session. The market value ...

Artelo Biosciences, Inc (ARTL) is a NASDAQ Common Stock listed in , ,

970x250